TW208004B - - Google Patents
Info
- Publication number
- TW208004B TW208004B TW081107481A TW81107481A TW208004B TW 208004 B TW208004 B TW 208004B TW 081107481 A TW081107481 A TW 081107481A TW 81107481 A TW81107481 A TW 81107481A TW 208004 B TW208004 B TW 208004B
- Authority
- TW
- Taiwan
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79078991A | 1991-11-12 | 1991-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW208004B true TW208004B (zh) | 1993-06-21 |
Family
ID=25151750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081107481A TW208004B (zh) | 1991-11-12 | 1992-09-22 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5536722A (zh) |
| EP (1) | EP0613477A1 (zh) |
| JP (1) | JPH07506084A (zh) |
| AU (1) | AU2599992A (zh) |
| CA (1) | CA2123402A1 (zh) |
| FI (1) | FI942188A (zh) |
| HU (1) | HUT69722A (zh) |
| IL (1) | IL103655A0 (zh) |
| MX (1) | MX9206468A (zh) |
| NO (1) | NO941785D0 (zh) |
| PT (1) | PT101046A (zh) |
| TW (1) | TW208004B (zh) |
| WO (1) | WO1993010116A1 (zh) |
| ZA (1) | ZA928683B (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO311614B1 (no) * | 1996-10-01 | 2001-12-17 | Janssen Pharmaceutica Nv | Substituerte diamino-1,3,5-triazinderivater |
| EP1053230A1 (en) * | 1998-01-13 | 2000-11-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| US6335339B1 (en) * | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| GB2336839A (en) * | 1998-04-30 | 1999-11-03 | Sharp Kk | Triazine Compounds And Their Use In Electrolumiescent, Electronic and Liquid Crystal Devices |
| AU740813B2 (en) * | 1998-07-08 | 2001-11-15 | Monash University | Pharmaceutical agents |
| US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
| US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| WO2000064880A1 (en) * | 1999-04-22 | 2000-11-02 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
| US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
| US6262053B1 (en) | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US7273880B2 (en) * | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| US7045247B1 (en) * | 2000-08-24 | 2006-05-16 | The Gillette Company | Battery cathode |
| US6376514B1 (en) * | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| JP2009545592A (ja) * | 2006-07-31 | 2009-12-24 | プリーシス・ファーマシューティカルズ・インコーポレイテッド | コード化小分子ライブラリーからのオーロラキナーゼ阻害剤 |
| US8835629B2 (en) | 2010-10-27 | 2014-09-16 | The Walter And Eliza Hall Institute Of Medical Research | Anti-cancer agents |
| KR101472083B1 (ko) * | 2012-10-22 | 2014-12-16 | 광주과학기술원 | ＥＮＯｂｌｏｃｋ을 유효성분으로 포함하는 암 예방 또는 치료용 약제학적 조성물 |
| JP2019064976A (ja) * | 2017-10-03 | 2019-04-25 | 国立大学法人 熊本大学 | 抗がん剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2524467A1 (fr) * | 1982-03-30 | 1983-10-07 | Adir | Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| DE68920798T2 (de) * | 1988-08-19 | 1995-05-18 | Warner Lambert Co | Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren. |
| FR2660558B1 (fr) * | 1990-04-05 | 1994-09-09 | Adir | Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme. |
| FR2664594B1 (fr) * | 1990-07-11 | 1992-09-18 | Adir | Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| ES2074867T3 (es) * | 1990-11-06 | 1995-09-16 | Pfizer | Derivados de quinazolina para potenciar la actividad antitumoral. |
| FR2673627B1 (fr) * | 1991-03-07 | 1993-05-07 | Adir | Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
-
1992
- 1992-09-16 JP JP5509227A patent/JPH07506084A/ja active Pending
- 1992-09-16 AU AU25999/92A patent/AU2599992A/en not_active Abandoned
- 1992-09-16 HU HU9401385A patent/HUT69722A/hu unknown
- 1992-09-16 EP EP92920143A patent/EP0613477A1/en not_active Withdrawn
- 1992-09-16 CA CA002123402A patent/CA2123402A1/en not_active Abandoned
- 1992-09-16 WO PCT/US1992/007656 patent/WO1993010116A1/en not_active Application Discontinuation
- 1992-09-16 US US08/232,083 patent/US5536722A/en not_active Expired - Fee Related
- 1992-09-22 TW TW081107481A patent/TW208004B/zh active
- 1992-11-05 IL IL103655A patent/IL103655A0/xx unknown
- 1992-11-10 PT PT101046A patent/PT101046A/pt not_active Application Discontinuation
- 1992-11-11 MX MX9206468A patent/MX9206468A/es unknown
- 1992-11-11 ZA ZA928683A patent/ZA928683B/xx unknown
-
1994
- 1994-05-11 FI FI942188A patent/FI942188A/fi not_active Application Discontinuation
- 1994-05-11 NO NO941785A patent/NO941785D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5536722A (en) | 1996-07-16 |
| EP0613477A1 (en) | 1994-09-07 |
| FI942188A0 (fi) | 1994-05-11 |
| HUT69722A (en) | 1995-09-28 |
| HU9401385D0 (en) | 1994-08-29 |
| IL103655A0 (en) | 1993-04-04 |
| ZA928683B (en) | 1994-05-11 |
| WO1993010116A1 (en) | 1993-05-27 |
| FI942188A (fi) | 1994-05-11 |
| NO941785L (no) | 1994-05-11 |
| MX9206468A (es) | 1993-05-01 |
| CA2123402A1 (en) | 1993-05-27 |
| NO941785D0 (no) | 1994-05-11 |
| JPH07506084A (ja) | 1995-07-06 |
| PT101046A (pt) | 1994-02-28 |
| AU2599992A (en) | 1993-06-15 |